Hedeker Wealth’s Harmony Biosciences HRMY Stock Holding History

Hedeker Wealth’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.9M	Buy	48,492 +2,235	+5%	+$86.4K	0.35%	60
2026 Q2	$1.68M	Sell	46,257 -14,608	-24%	-$461K	0.32%	63
2026 Q1	$1.7M	Sell	60,865 -12,705	-17%	-$417K	0.36%	61
2025 Q4	$2.75M	Sell	73,570 -6,675	-8%	-$219K	0.58%	48
2025 Q3	$2.21M	Buy	80,245 +1,340	+2%	+$46.2K	0.46%	52
2025 Q2	$2.49M	Buy	78,905 +1,171	+2%	+$37.7K	0.58%	48
2025 Q1	$2.58M	Buy	77,734 +1,531	+2%	+$54.9K	0.69%	47
2024 Q4	$2.62M	Buy	76,203 +916	+1%	+$31.5K	0.65%	46
2024 Q3	$3.01M	Buy	75,287 +2,662	+4%	+$93.5K	0.8%	45
2024 Q2	$2.19M	Sell	72,625 -5,598	-7%	-$168K	0.64%	49
2024 Q1	$2.63M	Buy	+78,223	New	+$2.51M	0.76%	48

Other funds holding HRMY

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Illumine Investment Management Poulsbo, Washington $144M AUM 33.61% 1-Year Est. Return

Hedeker Wealth's HRMY Position: Q3 2026 in Review

Hedeker Wealth increased its Harmony Biosciences (HRMY) stake by 4.8% in Q3 2026, buying an estimated $86.4K and bringing the position to 48,492 shares worth $1.9M. The position accounts for 0.35% of the portfolio, ranked #60.

Hedeker Wealth first reported a position in HRMY in Q1 2024 and has held it in 11 quarters since. The position peaked at $3.01M in Q3 2024. 52 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

Hedeker Wealth held 48,492 shares of Harmony Biosciences worth $1.9M as of Q3 2026.
Hedeker Wealth bought 2,235 Harmony Biosciences shares in Q3 2026, an estimated $86.4K.
Harmony Biosciences made up 0.35% of Hedeker Wealth's portfolio in Q3 2026, its #60 holding.
Hedeker Wealth first reported a position in Harmony Biosciences in Q1 2024 and has held it in 11 quarters since.
Hedeker Wealth's Harmony Biosciences position peaked at $3.01M in Q3 2024.
52 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Hedeker Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.